At the Center for Vaccine Research at the University of Pittsburgh, experts are studying a dead sample of the coronavirus, putting the facility at the forefront of research into the infection’s spread.
Matt Dunn, a researcher for the Center for Vaccine Research at the University of Pittsburgh, holds dead samples of the coronavirus Thursday, Feb. 27, 2020, at the Biomedical Science Tower 3 in Oakland. (Nate Guidry/ Post-Gazette)Matt Dunn, left, and Theron Gilliland Jr., researchers for the Center for Vaccine Research at the University of Pittsburgh, work with samples of the coronavirus Thursday, Feb. 27, 2020, at the Biomedical Science Tower 3 in Oakland. (Nate Guidry/ Post-Gazette)Matt Dunn, a researcher for the Center for Vaccine Research at the University of Pittsburgh, holds dead samples of the coronavirus Thursday, Feb. 27, 2020, at the Biomedical Science Tower 3 in Oakland. (Nate Guidry/ Post-Gazette)Dr. Sham Nambulli, a research scientist at the University of Pittsburgh Center for Vaccine Research, look at tissue cultures Thursday, Feb. 27, 2020, at the Biomedical Science Tower 3 in Oakland. (Nate Guidry/ Post-Gazette)Matt Dunn, left, and Theron Gilliland Jr., researchers for the Center for Vaccine Research at the University of Pittsburgh, work with samples of the coronavirus Thursday, Feb. 27, 2020, at the Biomedical Science Tower 3 in Oakland. (Nate Guidry/ Post-Gazette)Dr. Paul Duprex, director of the Center for Vaccine Research at the University of Pittsburgh, talks about the coronavirus Thursday, Feb. 27, 2020, at the Biomedical Science Tower 3 in Oakland. (Nate Guidry/ Post-Gazette)
By 
